278 related articles for article (PubMed ID: 9507212)
21. COL4A5 gene deletion and production of post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
Kalluri R; Weber M; Netzer KO; Sun MJ; Neilson EG; Hudson BG
Kidney Int; 1994 Mar; 45(3):721-6. PubMed ID: 8196274
[TBL] [Abstract][Full Text] [Related]
22. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.
Reynolds J; Prodromidi EI; Juggapah JK; Abbott DS; Holthaus KA; Kalluri R; Pusey CD
J Am Soc Nephrol; 2005 May; 16(5):1350-9. PubMed ID: 15814836
[TBL] [Abstract][Full Text] [Related]
23. Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies.
Kalluri R; Torre A; Shield CF; Zamborsky ED; Werner MC; Suchin E; Wolf G; Helmchen UM; van den Heuvel LP; Grossman R; Aradhye S; Neilson EG
Transplantation; 2000 Feb; 69(4):679-83. PubMed ID: 10708133
[TBL] [Abstract][Full Text] [Related]
24. Different immunologic properties of the globular NC1 domain of collagen type IV isolated from various human basement membranes.
Weber M; Pullig O
Eur J Clin Invest; 1992 Feb; 22(2):138-46. PubMed ID: 1374033
[TBL] [Abstract][Full Text] [Related]
25. Production and characterization of recombinant Goodpasture antigen in insect cells.
Turner N; Forstová J; Rees A; Pusey CD; Mason PJ
J Biol Chem; 1994 Jun; 269(25):17141-5. PubMed ID: 8006020
[TBL] [Abstract][Full Text] [Related]
26. Goodpasture antigen: expression of the full-length alpha3(IV) chain of collagen IV and localization of epitopes exclusively to the noncollagenous domain.
Leinonen A; Netzer KO; Boutaud A; Gunwar S; Hudson BG
Kidney Int; 1999 Mar; 55(3):926-35. PubMed ID: 10027929
[TBL] [Abstract][Full Text] [Related]
27. High nephritogenicity of monoclonal antibodies belonging to IgG2a and IgG2b subclasses in rat anti-GBM nephritis.
Kohda T; Okada S; Hayashi A; Kanzaki S; Ninomiya Y; Taki M; Sado Y
Kidney Int; 2004 Jul; 66(1):177-86. PubMed ID: 15200424
[TBL] [Abstract][Full Text] [Related]
28. Human Goodpasture anti-alpha3(IV)NC1 autoantibodies share structural determinants.
Meyers KE; Kinniry PA; Kalluri R; Neilson EG; Madaio MP
Kidney Int; 1998 Feb; 53(2):402-7. PubMed ID: 9461099
[TBL] [Abstract][Full Text] [Related]
29. Comparison of anti-GBM antibodies in sera with or without ANCA.
Hellmark T; Niles JL; Collins AB; McCluskey RT; Brunmark C
J Am Soc Nephrol; 1997 Mar; 8(3):376-85. PubMed ID: 9071706
[TBL] [Abstract][Full Text] [Related]
30. Nephritogenicity and alpha-chain composition of NC1 fractions of type IV collagen from bovine renal basement membrane.
Rauf S; Kagawa M; Kishiro Y; Inoue S; Naito I; Oohashi T; Sugimoto M; Ninomiya Y; Sado Y
Virchows Arch; 1996 Jul; 428(4-5):281-8. PubMed ID: 8764938
[TBL] [Abstract][Full Text] [Related]
31. The pathogenicity of T cell epitopes on human Goodpasture antigen and its critical amino acid motif.
Hu SY; Gu QH; Wang J; Wang M; Jia XY; Cui Z; Zhao MH
J Cell Mol Med; 2017 Sep; 21(9):2117-2128. PubMed ID: 28296059
[TBL] [Abstract][Full Text] [Related]
32. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen.
Savige JA; Gallicchio M
Clin Exp Immunol; 1991 Jun; 84(3):454-8. PubMed ID: 2044225
[TBL] [Abstract][Full Text] [Related]
33. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease.
Hellmark T; Segelmark M; Unger C; Burkhardt H; Saus J; Wieslander J
Kidney Int; 1999 Mar; 55(3):936-44. PubMed ID: 10027930
[TBL] [Abstract][Full Text] [Related]
34. Immunofluorescence study of type IV collagen alpha chains in epidermal basement membrane: application in diagnosis of X-linked Alport syndrome.
Ding J; Yang J; Liu J; Yu L
Chin Med J (Engl); 1997 Aug; 110(8):584-6. PubMed ID: 9594257
[TBL] [Abstract][Full Text] [Related]
35. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
Kalluri R; van den Heuvel LP; Smeets HJ; Schroder CH; Lemmink HH; Boutaud A; Neilson EG; Hudson BG
Kidney Int; 1995 Apr; 47(4):1199-204. PubMed ID: 7783419
[TBL] [Abstract][Full Text] [Related]
36. Glomerular basement membrane. Identification of dimeric subunits of the noncollagenous domain (hexamer) of collagen IV and the Goodpasture antigen.
Gunwar S; Ballester F; Kalluri R; Timoneda J; Chonko AM; Edwards SJ; Noelken ME; Hudson BG
J Biol Chem; 1991 Aug; 266(23):15318-24. PubMed ID: 1869555
[TBL] [Abstract][Full Text] [Related]
37. Epitope mapping of anti-glomerular basement membrane (GBM) antibodies with synthetic peptides.
Hellmark T; Brunmark C; Trojnar J; Wieslander J
Clin Exp Immunol; 1996 Sep; 105(3):504-10. PubMed ID: 8809141
[TBL] [Abstract][Full Text] [Related]
38. Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture's antigen.
Bolton WK; Chen L; Hellmark T; Wieslander J; Fox JW
J Am Soc Nephrol; 2005 Sep; 16(9):2657-66. PubMed ID: 16049074
[TBL] [Abstract][Full Text] [Related]
39. A nephritogenic peptide induces intermolecular epitope spreading on collagen IV in experimental autoimmune glomerulonephritis.
Chen L; Hellmark T; Pedchenko V; Hudson BG; Pusey CD; Fox JW; Bolton WK
J Am Soc Nephrol; 2006 Nov; 17(11):3076-81. PubMed ID: 17005930
[TBL] [Abstract][Full Text] [Related]
40. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.
Ryan JJ; Mason PJ; Pusey CD; Turner N
Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
